Cadila Heathcare Chairman Pankaj Patel On Consolidation In The Indian Industry And Why It's Not Happening Locally: An Interview With PharmAsia News
This article was originally published in PharmAsia News
Executive Summary
Pankaj Patel, chairman and managing director of India's fifth-largest firm Cadila Healthcare expresses an unswerving support for growth through partnerships. Riding on an early partnership with Swiss firm Nycomed and lucrative opportunities in niche segments like vaccines, Cadila's growth has been extraordinary - 18-fold growth in the last 15 years.
You may also be interested in...
Indian Pharma Should Give Up Their "Yogic" Ways To Win Global Markets
In order to gain a respectable rank on the global map, realignment of forces among Indian pharma is an imperative, Department Of Pharmaceuticals Joint Secretary Chaudhry exhorted Nov. 3 at the annual Pharma Summit organized by the Confederation of Indian Industry.
Hospira Hinges Emerging Market Success On Scale And Differentiation
Hospira Inc.'s new CEO Michael Ball laid out the company's strategic moves to expand in the fast-growing emerging markets during the company's Sept. 7 Investor's Day conference. The CEO said the U.S.-centric company's future growth hinges on expanding its footprint in emerging markets and launching more products including biosimilars in top pharmaceutical markets in Europe and Japan